Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 5:22 pm Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | ARMISTICE CAPITAL LLC | 7,358,000 9.620% | -290,000 (-3.79%) | Filing History |
| 2025-02-14 4:06 pm Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 2,114,056 2.400% | -2,226,284 (-51.29%) | Filing History |
| 2025-02-14 09:10 am Purchase | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Rock Springs Capital Management LP | 4,973,649 5.720% | 561,666 (+12.73%) | Filing History |
| 2025-02-07 07:44 am Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | MACQUARIE GROUP LTD | 4,259,557 4.900% | -486,587 (-10.25%) | Filing History |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | BlackRock Inc. BLK | 8,018,292 9.400% | 28,272 (+0.35%) | Filing History |
| 2025-01-31 10:09 am Sale | 2024-12-31 | 13G | Travere Therapeutics, Inc. TVTX | VANGUARD GROUP INC | 6,742,165 7.750% | -159,985 (-2.32%) | Filing History |
| 2024-11-14 5:13 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | ARMISTICE CAPITAL LLC | 7,648,000 10.000% | 264,000 (+3.58%) | Filing History |
| 2024-11-14 1:01 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Woodline Partners LP | 4,340,340 5.700% | 4,340,340 (New Position) | Filing History |
| 2024-11-14 09:46 am Sale | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 531,857 0.700% | -6,990,424 (-92.93%) | Filing History |
| 2024-11-12 5:56 pm Unchanged | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | VANGUARD GROUP INC | 6,902,150 9.020% | 0 (Unchanged) | Filing History |
| 2024-11-08 4:55 pm Sale | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | MORGAN STANLEY MS | 1,319,809 1.700% | -2,832,637 (-68.22%) | Filing History |
| 2024-11-04 1:55 pm Purchase | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | VANGUARD GROUP INC | 6,902,150 9.020% | 1,387,007 (+25.15%) | Filing History |
| 2024-10-18 11:59 am Sale | 2024-09-30 | 13G | Travere Therapeutics, Inc. TVTX | STATE STREET CORP STT | 2,736,696 3.600% | -2,615,649 (-48.87%) | Filing History |
| 2024-05-01 4:11 pm Purchase | 2024-04-25 | 13G | Travere Therapeutics, Inc. TVTX | Rock Springs Capital Management LP | 4,411,983 5.790% | 4,411,983 (New Position) | Filing History |
| 2024-02-14 2:35 pm Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | ARMISTICE CAPITAL LLC | 7,384,000 9.830% | 972,000 (+15.16%) | Filing History |
| 2024-02-14 08:58 am Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 7,522,281 9.990% | 2,940,281 (+64.17%) | Filing History |
| 2024-02-14 06:38 am Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | MACQUARIE GROUP LTD | 4,746,144 6.310% | 1,190,152 (+33.47%) | Filing History |
| 2024-02-13 5:16 pm Purchase | 2023-12-29 | 13G | Travere Therapeutics, Inc. TVTX | VANGUARD GROUP INC | 5,515,143 7.340% | 1,999,697 (+56.88%) | Filing History |
| 2024-02-12 2:58 pm Sale | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | JANUS HENDERSON GROUP PLC JHG | 32,180 0.000% | -5,059,105 (-99.37%) | Filing History |
| 2024-02-09 10:33 am Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | MORGAN STANLEY MS | 4,152,446 5.500% | 4,152,446 (New Position) | Filing History |